PUBLICATIONS · 33568345
Activity of Crizotinib in Patients with ALK-Aberrant Relapsed/Refractory Neuroblastoma: A Children's Oncology Group Study (ADVL0912).
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Clin Cancer Res
- Publication date
- 2021 Jul 1
- First author
- Foster JH
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Clin Cancer Res. 2021 Jul 1;27(13):3507-3509. doi: 10.1158/1078-0432.CCR-21-0627.
- note
- Source null
- related pmid
- 33947691
- relationship
- Comment in
Authors and identifiers
- name
- Foster JH
- type
- Author
- name
- Voss SD
- type
- Author
- name
- Hall DC
- type
- Author
- name
- Minard CG
- type
- Author
- name
- Balis FM
- type
- Author
- name
- Wilner K
- type
- Author
- name
- Berg SL
- type
- Author
- name
- Fox E
- type
- Author
- name
- Adamson PC
- type
- Author
- name
- Blaney SM
- type
- Author
- name
- Weigel BJ
- type
- Author
- name
- Mossé YP
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Foster JH
- type
- Author
- name
- Voss SD
- type
- Author
- name
- Hall DC
- type
- Author
- name
- Minard CG
- type
- Author
- name
- Balis FM
- type
- Author
- name
- Wilner K
- type
- Author
- name
- Berg SL
- type
- Author
- name
- Fox E
- type
- Author
- name
- Adamson PC
- type
- Author
- name
- Blaney SM
- type
- Author
- name
- Weigel BJ
- type
- Author
- name
- Mossé YP
- type
- Author
- bibliography ids
- nci-bib-845b8a2d5ddb584b20f797d2
- book metadata
- content sha256
- eebf3f1b016d2aed0d54e2e428c91a6adfd99b404d7212efbf1ac6f4477bcadf
- document type
- citation
- dois
- 10.1158/1078-0432.CCR-20-4224
- electronic publication date
- display
- 2021 Feb 10
- precision
- day
- year
- 2021
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:33568345
- immutable id
- pubmed:33568345@eebf3f1b016d2aed0d54e2e428c91a6adfd99b404d7212efbf1ac6f4477bcadf
- journal
- abbreviation
- Clin Cancer Res
- issn electronic
- 1557-3265
- issn print
- 1078-0432
- issue
- 13
- name
- Clinical cancer research : an official journal of the American Association for Cancer Research
- nlm unique id
- 9502500
- pages
- 3543-3548
- volume
- 27
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Clin Cancer Res. 2021 Jul 1;27(13):3507-3509. doi: 10.1158/1078-0432.CCR-21-0627.
- note
- Source null
- related pmid
- 33947691
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 33568345
- provenance
- batch id
- 79f1021053e858d13ff3
- provider
- NCBI PubMed ESummary
- record sha256
- 9eaa4eca117c8b7a600dab0fc19bfa507e0e20d055b5a2f62031e7c9bb9d3f28
- response sha256
- 671d3d2962f73c698a1cb338d73222e2cc6cfdf61569f91b42612d5b59822e05
- retrieved at
- 2026-09-09T23:47:59.098265+00:00
- publication date
- display
- 2021 Jul 1
- precision
- day
- year
- 2021
- publication types
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Activity of Crizotinib in Patients with ALK-Aberrant Relapsed/Refractory Neuroblastoma: A Children's Oncology Group Study (ADVL0912).
Preserved source evidence · Not medical advice
Triangle